Evidence map›Paper›PMID 39643480›Full record

Trial reportBrain and behavior2024

Feasibility of Fish Oil Supplementation on Headache Symptoms and Blood Lipids in Migraine Patients.

En-Ling Yeh, Chun-Pai Yang, Shu-Wen Lin, Hsueh-Fang Wang

Abstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Brain and behavior, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

En-Ling YehDepartment of Nutrition, Hungkuang University, Taichung, Taiwan.
Chun-Pai YangDepartment of Nutrition, Hungkuang University, Taichung, Taiwan.
Shu-Wen LinDepartment of Nutrition, Kuang Tien General Hospital, Taichung, Taiwan.
Hsueh-Fang WangDepartment of Nutrition, Hungkuang University, Taichung, Taiwan.ORCID 0009-0006-1361-1486

Funding

Kuang Tien General Hospital and Hungkuang University HK-KTOH-110-05Kuang Tien General Hospital and Hungkuang University HK-KTOH-111-04Ministry of Science and Technology of Taiwan MOST 110-2635-B-241-001
6 · The paper itself

Abstract

objectivesMigraine is a chronic, recurring, and disabling disease. Fish oil intervention was used to investigate its effects on headache symptoms and blood lipids of migraine patients.

designAll subjects were collected at the Kuang Tian General Hospital from March 2020 to May 2021. Experimental group subjects took 1 g/time of fish oil (including EPA 900 mg/tablet) after breakfast and dinner. Placebo group subjects took 100% soybean oil twice daily. Before and after the test, the migraine improvement questionnaire was used to analyze headaches during attacks, dietary intake, and headache triggers.

resultsThe average age of the 47 subjects in this study was 40.3 ± 9.2 years old, the body mass index (BMI) was 24.3 ± 6.0 kg/m

conclusionFish oil may be used as an adjunctive therapeutic food for relieving migraine attack symptoms and blood lipids.

Indexed as

Dietary SupplementsFeasibility StudiesFish OilsMigraine DisordersAdultEicosapentaenoic AcidFemaleHeadacheHumansLipidsMaleMiddle AgedEicosapentaenoic AcidFish OilsLipidsblood lipidfish oilheadache symptommigraine

Identifiers

PMID39643480
PMCPMC11624007

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.